[go: up one dir, main page]

BR0007491A - Use of 3-isoxazolidinones and hydroxylamic acids to treat infections - Google Patents

Use of 3-isoxazolidinones and hydroxylamic acids to treat infections

Info

Publication number
BR0007491A
BR0007491A BR0007491-8A BR0007491A BR0007491A BR 0007491 A BR0007491 A BR 0007491A BR 0007491 A BR0007491 A BR 0007491A BR 0007491 A BR0007491 A BR 0007491A
Authority
BR
Brazil
Prior art keywords
hydroxylamic
isoxazolidinones
acids
treat infections
infections
Prior art date
Application number
BR0007491-8A
Other languages
Portuguese (pt)
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19903666A external-priority patent/DE19903666A1/en
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of BR0007491A publication Critical patent/BR0007491A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "USO DE 3-ISOXAZOLIDINONAS EáCIDOS HIDROXILâMICOS PARA O TRATAMENTO DEINFECçõES". A invenção refere-se aos medicamentos com umconteúdo de pelo menos um composto da fórmula geral (I) e seuuso para o tratamento terapêutico e profilático de infecções emseres humanos e animais causadas por bactérias, fungos eparasitas.Invention Patent: "USE OF 3-ISOXAZOLIDINONES HYDROXYLAMIC ACIDS FOR THE TREATMENT OF INFECTIONS". The invention relates to medicines with a content of at least one compound of the general formula (I) and its use for the therapeutic and prophylactic treatment of infections in humans and animals caused by bacteria, fungi and parasites.

BR0007491-8A 1999-01-13 2000-01-12 Use of 3-isoxazolidinones and hydroxylamic acids to treat infections BR0007491A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19900907 1999-01-13
DE19903666A DE19903666A1 (en) 1999-01-13 1999-01-30 Medicines containing 3-isoxazolidinones and hydroxylamic acids as an active ingredient and their use
PCT/EP2000/000165 WO2000041473A2 (en) 1999-01-13 2000-01-12 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections

Publications (1)

Publication Number Publication Date
BR0007491A true BR0007491A (en) 2001-11-20

Family

ID=26051290

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007491-8A BR0007491A (en) 1999-01-13 2000-01-12 Use of 3-isoxazolidinones and hydroxylamic acids to treat infections

Country Status (14)

Country Link
EP (1) EP1143941A3 (en)
JP (1) JP2002534440A (en)
CN (1) CN1342078A (en)
AU (1) AU2436600A (en)
BR (1) BR0007491A (en)
CA (1) CA2360366A1 (en)
CZ (1) CZ20012380A3 (en)
HU (1) HUP0105412A2 (en)
IL (1) IL143795A0 (en)
NO (1) NO20013464L (en)
PL (1) PL350128A1 (en)
SK (1) SK9502001A3 (en)
TR (1) TR200102019T2 (en)
WO (1) WO2000041473A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005512975A (en) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ Isoxazoline derivatives useful as antibacterial agents
GB202209172D0 (en) * 2022-06-22 2022-08-10 Syngenta Crop Protection Ag Improvements in or relating to organic compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45174A (en) * 1973-08-10 1976-12-31 Merck & Co Inc Antibacterial compositions containing 3-fluoro-d-alanine type compound and n-substituted cycloserine compound
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FR2290442A1 (en) * 1974-11-06 1976-06-04 Aries Robert Cycloserine-(hexahydro)rifamycin SV condensates - antibiotics, prepd from 3-formyl rifamycins and opt N-alkylated cycloserine
DE3686632T2 (en) * 1985-04-30 1993-01-21 Takeda Chemical Industries Ltd ANTIBIOTIC DERIVATIVES, THEIR PRODUCTION AND USE.
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
JPS63119462A (en) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd 5-membered-ring n-sulfo compound
JPS63119476A (en) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd Isoxazolidone derivative
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
WO1994021625A1 (en) * 1993-03-16 1994-09-29 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as metalloproteinase inhibitors
NZ271893A (en) * 1993-08-23 1997-11-24 Immunex Corp Inhibitors of tnf-alpha secretion
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
WO1996013263A2 (en) * 1994-11-01 1996-05-09 Research Corporation Technologies, Inc. Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
US5919790A (en) * 1996-10-11 1999-07-06 Warner-Lambert Company Hydroxamate inhibitors of interleukin-1β converting enzyme
AU6843298A (en) * 1997-03-28 1998-10-22 Zeneca Limited Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds

Also Published As

Publication number Publication date
WO2000041473A3 (en) 2001-11-29
NO20013464D0 (en) 2001-07-12
SK9502001A3 (en) 2002-05-09
IL143795A0 (en) 2002-04-21
NO20013464L (en) 2001-09-12
PL350128A1 (en) 2002-11-04
AU2436600A (en) 2000-08-01
CA2360366A1 (en) 2000-07-20
HUP0105412A2 (en) 2002-05-29
EP1143941A2 (en) 2001-10-17
EP1143941A3 (en) 2002-02-06
CZ20012380A3 (en) 2002-01-16
JP2002534440A (en) 2002-10-15
CN1342078A (en) 2002-03-27
WO2000041473A2 (en) 2000-07-20
TR200102019T2 (en) 2002-04-22

Similar Documents

Publication Publication Date Title
BR9909668A (en) Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections
NO20025450D0 (en) New pharmaceutical composition
BR0116370A (en) Compound, pharmaceutical composition, use of a compound, and method of treating an hppar-mediated disease or condition in a patient.
EA200100524A1 (en) AMIDES OF ANTRANILIC ACID AND THEIR APPLICATION AS MEDICINES
DK1411932T3 (en) Combination therapy with substituted oxazolidinones
WO2001045679A3 (en) Use of chemotherapeutic agents for topical treatment
BRPI0013010B8 (en) aqueous formulation of moxifloxacin sodium chloride, process for its preparation and application of said formulation, as well as preparation for combining and applying an aqueous solution of moxifloxacin hydrochloride
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
BR9712141A (en) Application of 1-hyphroxy-2-pyridones to treat skin infections.
EA200400214A1 (en) AZITROMYCIN IN THE FORM OF SINGLE DOSE
RS8504A (en) Novel cyclohexil sulphones
PT1140113E (en) USE OF BISPHOSPHANTS FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS PROCESSES
SE0004101D0 (en) New use
BR0006301A (en) Antibacterial and prokinetic macrolides
BR0015722A (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
DE50113974D1 (en) COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES WITH SPECIAL PHARMACEUTICAL ACTIVE SUBSTANCES
BR9913990A (en) Use of organophosphate compounds for the production of pharmaceutical preparations for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide in plants
BR0007491A (en) Use of 3-isoxazolidinones and hydroxylamic acids to treat infections
ATE344662T1 (en) AGENTS CONTAINING N-CHLORTAURINE AND THEIR USE FOR THE TREATMENT OF MUCOUS POLYPS
ATE317263T1 (en) DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC SUBSTANCES
BR0005061A (en) Gastric Acid Secretion
BR9915639A (en) Use of phosphonoformic acid derivatives to treat infections
ATE308895T1 (en) TREATMENT OF INFECTIONS IN ANIMALS
DE60003074D1 (en) Fusidic DERIVATIVES
IT1265647B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ALLERGIES

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]